COMMUNIQUÉS West-GlobeNewswire

Esteworld Concludes Four-Day Consultation Series at Covent Garden, London
17/09/2025
Photo: Esteworld Representative Office - Covent Garden, London LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Esteworld Health Group has concluded a four-day series of face-to-face consultation sessions at its Covent Garden [...]
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
17/09/2025
Representing 10 U.S. states and Puerto Rico, finalists will compete in Washington, D.C., for more than $100,000 in awards WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 [...]
Amid 7-OH Health Warnings, Happy Go Leafy Introduces Pure Kratom Line for Safer Wellness
17/09/2025
Happy Go Leafy responds to 7-OH concerns with a new pure kratom line. Lab-tested and transparent products designed to support safer wellness use. Miami, Florida, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 2025 has seen urgent [...]
The Association of American Physicians and Surgeons (AAPS) Supports HHS Secretary Kennedy and Making America Healthy Again (MAHA)
17/09/2025
TUCSON, Ariz., Sept. 17, 2025 (GLOBE NEWSWIRE) -- On September 13, at its 82 nd annual meeting in Chantilly, VA, the Association of American Physicians and Surgeons (AAPS) passed the following emergency resolution, [...]
Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
17/09/2025
NEEDHAM, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
iPETcertum™ by Claritas, State-of-the-Art Software for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scans, Receives Clearance from Brazilian Regulator ANVISA
17/09/2025
NEW YORK and LONDON and SAO PAULO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Claritas NucMed Tech Brazil S.A. (“Claritas NucMed Brazil”), a subsidiary of UK-based Claritas NucMed Technologies Ltd (“Claritas NucMed”), a company [...]
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System
17/09/2025
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
CDT Executes Cryptocurrency Treasury Reserve Strategy
17/09/2025
Initial digital asset acquisition marks milestone in capital diversification initiative NAPLES, Fla. And CAMBRIDGE, United Kingdom, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT ) (“CDT” or the “ [...]
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
17/09/2025
The European Journal of Pediatrics publishes the first-ever multicenter clinical trial results demonstrating that the Vivos DNA appliance — part of the company’s C.A.R.E. line of devices— is both safe and effective for [...]
Safety Shot Announces Strategic Board Refresh to Align with New Corporate Vision
17/09/2025
Company Appoints New Directors with Deep Expertise in Venture Capital, Financial Due Diligence, and Bitcoin Mining to Guide Next Phase of Growth SCOTTSDALE, AZ, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. ( [...]
Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
17/09/2025
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly [...]
Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research
17/09/2025
Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to reprogram the ovarian tumor microenvironment and advance toward clinical trials CAMBRIDGE, Mass., [...]
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
17/09/2025
Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) services MALVERN, Pa., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company [...]
Digital Utilities Ventures Provides Corporate Update
17/09/2025
International contracts, pending FINRA approvals, and OTCQB uplisting efforts position DUTV for expanded revenues and improved market visibility MANKATO, Minn., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Digital Utilities [...]
PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference
17/09/2025
PETACH TIKVA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that management will [...]
Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment
17/09/2025
Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA Approval KANSAS CITY, Kan., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company [...]
Akari Therapeutics Announces Filing for New Patent for Novel ADC Platform Utilizing Spliceosome Payload PH1 for the Treatment of Cancer
17/09/2025
BOSTON and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has filed [...]
Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office
17/09/2025
Fourth US Granted Patent Captures Claims for Future Clinical Dose of PRP MELBOURNE, Australia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical [...]
NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
17/09/2025
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR) technology has been approved for evaluation in the clinic by the UK’s Medicine [...]

Pages